Cns Pharmaceuticals Stock Forecast - Accumulation Distribution
| CNSP Stock | USD 0.12 0.01 7.69% |
Cns Stock Forecast is based on your current time horizon. Although Cns Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Cns Pharmaceuticals' systematic risk associated with finding meaningful patterns of Cns Pharmaceuticals fundamentals over time.
Cns |
| Check Cns Pharmaceuticals Volatility | Backtest Cns Pharmaceuticals | Information Ratio |
Cns Pharmaceuticals Trading Date Momentum
| On November 25 2024 Cns Pharmaceuticals was traded for 0.12 at the closing time. The top price for the day was 0.13 and the lowest listed price was 0.11 . There was no trading activity during the period 0.0. Lack of trading volume on November 25, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Cns Pharmaceuticals to competition |
Other Forecasting Options for Cns Pharmaceuticals
For every potential investor in Cns, whether a beginner or expert, Cns Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cns Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cns. Basic forecasting techniques help filter out the noise by identifying Cns Pharmaceuticals' price trends.Cns Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cns Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Cns Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cns Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cns Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cns Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cns Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cns Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Cns Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cns Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Cns Pharmaceuticals stock market strength indicators, traders can identify Cns Pharmaceuticals entry and exit signals to maximize returns.
Cns Pharmaceuticals Risk Indicators
The analysis of Cns Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cns Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cns stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.99 | |||
| Standard Deviation | 7.38 | |||
| Variance | 54.52 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Cns Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cns Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Cns Stock
Moving against Cns Stock
| 0.72 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.7 | GILD | Gilead Sciences | PairCorr |
| 0.68 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.6 | KZR | Kezar Life Sciences | PairCorr |
| 0.59 | VRDN | Viridian Therapeutics | PairCorr |
The ability to find closely correlated positions to Cns Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cns Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cns Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cns Pharmaceuticals to buy it.
The correlation of Cns Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cns Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cns Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cns Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Cns Stock Analysis
When running Cns Pharmaceuticals' price analysis, check to measure Cns Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cns Pharmaceuticals is operating at the current time. Most of Cns Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cns Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cns Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cns Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.